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ABSTRACT Promoter proximal pausing (PPP) of RNA polymerase II has emerged as a crucial rate-limiting step in the regulation of gene
expression. Regulation of PPP is brought about by complexes 7SK snRNP, P-TEFb (Cdk9/cycT), and the negative elongation factor
(NELF), which are highly conserved from Drosophila to humans. Here, we show that RNAi-mediated depletion of bin3 or Hexim of the
7SK snRNP complex or depletion of individual components of the NELF complex enhances Yki-driven growth, leading to neoplastic
transformation of Drosophila wing imaginal discs. We also show that increased CDK9 expression cooperates with Yki in driving
neoplastic growth. Interestingly, overexpression of CDK9 on its own or in the background of depletion of one of the components
of 7SK snRNP or the NELF complex necessarily, and specifically, needed Yki overexpression to cause tumorous growth. Genome-wide
gene expression analyses suggested that deregulation of protein homeostasis is associated with tumorous growth of wing imaginal
discs. As both Fat/Hippo/Yki pathway and PPP are highly conserved, our observations may provide insights into mechanisms of
oncogenic function of YAP—the ortholog of Yki in humans.
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REGULATION of growth is arguably the most critical phe-nomenon that establishes size and shape of all tissues,
organs, andoverall body size inmetazoananimals . It is also an
important homeostatic process, failure of which is linked to
diseases and disorders, particularly cancer in humans. Regu-
lated growth is achieved by an intricate interplay between
factors promoting growth (oncogenes) and those suppressing
it (tumor suppressors).
Yorkie (Yki), theDrosophila ortholog of the Yes-Associated
Protein 1 (YAP1), acts as a transcriptional cofactor that
mediates the effects of the Hippo tumor suppressor pathway.
The Hippo pathway is highly conserved from Drosophila to
humans (Pan 2010). The Hippo (Hpo)/MST kinases and the
Warts (Wts)/LATS kinases and their cofactors form kinase
cassettes that directly phosphorylate Yki (YAP/TAZ) to reg-
ulate protein stability and activity (Zhao et al. 2011). Mem-
bers of this pathway were initially found to limit tissue
growth in Drosophila by limiting Yki activity (Huang et al.
2005; Dong et al. 2007). Consistent with this, YAP overex-
pression has been reported as a driver of tissue growth and
cancer in a mouse model (Dong et al. 2007; Zanconato et al.
2015). In humans, the YAP1 locus was found to be amplified
in different types of cancer (Overholtzer et al. 2006; Zender
et al. 2006). These findings have sparked a great deal of in-
terest in understanding of regulation of Yki/YAP function.
In Drosophila, Yki regulates expression of regulators of cell
growth and survival such as Diap1, dMyc, bantam, etc. Targets
of YAP in humans include the EGFR-ligand AREG as well as
CTGF, Cyr61 (Johnson and Halder 2014). While these target
genes are necessary for growth induced by Yki/YAP activity,
they are not sufficient to phenocopy effects of Yki/YAP. This
indicates possibility of more regulators that are involved in
Yki/YAP induced growth.
We have reported an in vivo screen in Drosophila (Groth
et al. 2020), wherein we have identified a large number of
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genes, which, when depleted, enhanced growth induced by
Yki and EGFR. More importantly, these genes function like
classical tumor suppressors as, when downregulated in the
background of overexpressed Yki or EGFR, we observed neo-
plastic growth. Among these, we identified a number of genes
involved in the control of promoter proximal transcriptional
pausing.
Promoter proximal pausing (PPP) of RNA polymerase
(Pol) II has been identified as a key step in transcriptional
regulation for many genes, during development and in stem
cells (Guenther et al. 2007; Muse et al. 2007; Zeitlinger et al.
2007). At paused loci, after initiation, RNA Pol II first passes
through the promoter but then stops at 30–60 bp from the
transcription start site (Kwak and Lis 2013). Productive tran-
scription then requires release from the paused state. PPP is
brought about by the negative transcription elongation factor
(NELF) and 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole
(DRB)-sensitivity inducing factor (DSIF) protein com-
plexes, which were identified as factors responsible for DRB
sensitivity of transcription elongation (Wada et al. 1998;
Yamaguchi et al. 1999). These complexes bind RNA Pol II
and halt its progress downstream of the promoter. This pause
is alleviated by a positive transcription elongation factor com-
plex (P-TEFb) (Figure 1A), which consists of cyclin T and
cyclin dependent kinase-CDK9 (Marshall and Price 1995).
Once recruited to the paused complex, CDK9 phosphorylates
NELF and DSIF leading to ejection of NELF from the paused
complex while DSIF assists Ser-5 phosphorylated RNA Pol II
in productive elongation (Jonkers and Lis 2015). The PTEFb
complex is, in turn, regulated through sequestration by 7SK
snRNP complex. P-TEFb is required for release paused RNA
polymerase II into productive elongation (Kwak and Lis
2013). Sequestration of P-TEFb by 7SK snRNP leads to its
unavailability for mediating pause release, which, in turn,
regulates transcription elongation via sustained pause of
RNA Pol II. Mammalian 7sk-snRNP complex consists of 7sk
RNA, Hexim1/2, Larp7, and MePCE. Drosophila homologs of
components of mammalian 7sk-snRNP complex were identi-
fied and characterized recently (Nguyen et al. 2012). These
include Bin3 (MePCE ortholog), Larp (Larp7 ortholog),
Hexim (HEXIM1/2 ortholog), and d7SK RNA. All are highly
conserved at functional levels with their mammalian coun-
terparts. Signaling events of pathways such as ERK, TCR,
etc., trigger liberation of P-TEFb. Thus, making sequestration
and liberation of P-TEFb a context dependent process that is
critical for regulating expression of gene regulation depend-
ing on the context.
Interestingly, CDK9 has been shown to be important for
transcription of target genes of oncogenes such as Myc
(Kanazawa et al. 2003) and YAP (Galli et al. 2015). Here,
we present evidence of tumor suppressor function of vari-
ous components involved in PPP, specifically in the context
of elevated Yki activity. Our findings show that factors in-
volved in PPP and its regulation are important to restrict
Yki driven growth and to prevent neoplastic transforma-
tion in vivo.
Material and Methods
Drosophila strains
The following Drosophila strains are used in this study: ap-Gal4
(Cohen et al. 1992) and UAS-Yki (Huang et al. 2005). The fol-
lowing RNAi stocks were obtained from the Vienna Drosophila
RNAi Center and BloomingtonDrosophila stock Center:UAS-Nel-
fARNAi (KK106245, TRiP #32897), UAS-NelfBRNAi (KK108441,
TRiP #42547), UAS-NelfERNAi (TRiP # 32835), UAS-NelfDRNAi
(KK100009, TRiP # 38934, #42931), UAS-bin3RNAi (KK101090,
TRiP #41527), UAS-HeximRNAi (KK100500). UAS-CDK9 was
obtained from FlyORF (#F001571).
Spatio-temporal regulation of transgene expression in
wing imaginal disc
The apterous enhancer was used to drive expression of Gal4
conditionally in dorsal compartment of wing imaginal discs.
Gal4 activity was regulated using Gal80TS, which allows expres-
sion of transgenes at permissive temperature of 29 as against
restrictive 18 temperature. In all experiments, tubulin-Gal80TS
was used.Drosophila crosseswere allowed to lay eggs for 3 days
at 18, and were then flipped or discarded. Larvae were then
allowed to grow for additional 5 days before switching to tem-
perature of 29. At 29 they were maintained for 4–14 days. All
crosses were using tubulin-GAL80TS; ap-GAL4; UAS-GFP. Thus,
all experimental crosses had one copy of GFP, while control
crosses had two copies ofGFP. Detailedmethodology is provided
in Groth et al. (2020). Larval images were taken in bright field
and in GFP channel with a Leica stereomicroscope. Image pro-
cessing was done using Adobe Photoshop 6 and ImageJ.
Immunohistochemistry
The following primary antibodieswere used: rat anti-Ecadherin,
mouse anti-MMP1 (Developmental Studies Hybridoma Bank).
Rhodamine-phalloidin (ThermoFisher Scientific, Cat no R415)
was used to stain actin in tissue.
Third instar larvae were dissected in PBS. Samples were
fixed in 4% PFA for 20 min, followed by three 10-min washes
in PBT (PBS-Tween20) at room temperature. Then, 5% BSA in
PBS was used for blocking followed by overnight incubation in
primary antibody at 4. Next day, the samples were washed
with PBT, three times for 10 min each followed by incubation
with secondary antibody for 2 hr at room temperature. Sam-
ples were then washed with PBT and stained for DNA using
49,6-diamidino-2-phenylindole (DAPI; Sigma Aldrich) for
5 min. Wing disc tissue was then mounted on slides in Anti-
fade Gold mountant (ThermoFisher Scientific). Imaging was
done on a Leica SP8 confocal laser-scanning microscope. Im-
age processing was done using ImageJ and Adobe Photoshop
6. Measurement MMP1 intensities and comparison between
different genotypes was carried out using ImageJ, statistical
analysis (one-way ANOVA)was done using Prism-Graphpad 5.
RNA-seq
Induction procedure for transgenes was followed as men-
tioned earlier. Wing imaginal disc tissue was dissected on
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4th–5th day after induction for ap. GFP, ap. UAS-Yki, ap.
Nelf-A RNAi (KK106245), ap . UAS-Yki, UAS Nelf-A RNAi.
Larvae were washed in RNase-, DNase-free ultrapure water
(GiBCO), and then dissections were done in RNase-, DNase-
free PBS (GiBCo). Number of wing imaginal discs collected
was 150, 70, 150, 25, respectively for ap . GFP, ap . UAS-
Yki, ap . Nelf-A RNAi (KK106245), ap . UAS-Yki, and
UAS Nelf-A RNAi. Collection was done in TRiZOL reagent
(ThermoFisher Scientific). Each genotype was collected in
three biological replicates. RNA sequencing was done on
an Illumina platform.
RNA-seq data analysis
RNA-seq analysiswas performedusing theHISAT2.0 package
protocol as explained in Pertea et al. (2016). To identify
significantly differentially expressing genes in different com-
binations of comparisons, DEseq package and EdgeR were
used (Anders and Huber 2010). The entire RNA-seq data
set is available on GEO database (https://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE151935).
The list of genes obtained was then used as input for the
web-based tool venny (http://bioinfogp.cnb.csic.es/tools/
venny/index.html) to obtain a list of genes that are unique
to each genotype, overlapping between all three or combina-
tion of any two genotypes.
Gene ontology analysis
For geneontology (GO)andpathwayenrichment analysis,we
utilized STRING10 (Szklarczyk et al. 2017). We used gene
lists that are significantly differentially expressed in single
Figure 1 Identification of complexes involved in promoter proximal pausing as tumor suppressors. (A) A schematic representing known function of two
complexes we identified as candidate tumor suppressors. The 7SK snRNP complex regulates promoter proximal pausing by sequestring the P-TEFb
complex, while the NELF complex is involved in the formation of a stall of RNA Pol II at the promoter proximal region. As dictated by surrounding cues,
P-TEFb is released by the 7SK snRNP complex. Thus, freed P-TEFb is recruited to stalled RNA Pol II, where it brings about release of RNA Pol II from the
paused state. (B) Larval images showing wing imaginal discs expressing GFP at low magnification. Dimensions of GFP-expressing tissue is indication of
growth in imaginal discs. Top row: Larvae overexpressing only Yki (crossed to UAS-GFP as control) and those in combination with RNAi-mediated
knockdown of 7sksnRNP components: Hexim or bin3 using GAL80TS; ap-GAL4; UAS-GFP. Bottom row: wing discs overexpressing Yki in combination
with RNAi-mediated knockdown of NELF components (from left to right) NelfA, NelfB, and NelfD (also known as TH1) using GAL80TS; ap-GAL4; UAS-
GFP. Note significantly larger GFP expressing-wing discs (green) in larvae that are overexpressing Yki and also depleted for a component of PPP.
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genotype or a combination of genotypes as mentioned in the
results section, as input to the STRING. The output files were
downloaded as interaction network and list of genes from
input that are enriched in different GO categories or as KEGG
pathways.
Data availability
The authors state that all data necessary for confirming the
conclusions presented in the article are represented fully
within the article. All Drosophila stocks are available upon
request. RNA-seq data are available at GEO with the acces-
sion number: GSE151935. Supplemental material available
at figshare: https://doi.org/10.25386/genetics.12689318.
Results
Depletion 7SK snRNP complex components cooperates
with Yki in causing tumorous growth
Studies using Drosophila tumor models have found that lar-
vae containing proliferating tumors are unable to enter
pupariation and continue to grow (Gateff et al. 1993). The
resulting giant larva phenotype can be used in genetic screens
to identify tumor-causing genotypes. We made use of this
property to identify candidate genes in a genetic screen for
tumor suppressors cooperating with Yki [the entire screen is
published elsewhere (Groth et al. 2019)]. We found that
RNAi-mediated depletion of bin3 or Hexim, components of
the 7SK snRNA complex in combination with Yki overexpres-
sion led to massive overgrowth in wing disc tissue and giant
larval phenotype (Figure 1B). Wing discs expressing Yki
alone show only moderate overgrowth phenotype, and lar-
vae eventually pupate (Figure 1B). Depletion of 7SK snRNP
components did not produce overgrowth on their own (Sup-
plemental Material, Figure S1), but only did so when coupled
with Yki overexpression. We also did not observe wing disc
overgrowth when depletion of 7SK snRNP components in
combination with overexpression of other well-known onco-
proteins such as epidermal growth factor receptor (EGFR) or
notch intracellular domain (NICD) (Figure S2). Thus, our
observations suggest that, Drosophila 7SK snRNP complex
may function, specifically, to repress tumorigenic potential
of Yki in vivo in an epithelial tumor model.
Components of the NELF complex may function as
tumor suppressors
The NELF complex is composed of four subunits: NELF-A, -B,
-C/-D and -E. Depletion of each of theNELF components using
RNAi in combination with Yki also produced a giant larval
phenotype (Figure 1B) and massively overgrown wing disc
tissue compared to the larvae overexpressing only Yki (Figure
Figure 2 Characterization of tumors induced in the wing disc. (A) Disruption of characteristic epithelial apico-basal polarity in tumor discs. Images of
wing discs overexpressing Yki alone (crossed to UAS-GFP as control) or in combination with RNAi-mediated knockdown of Hexim, bin3, NelfA or NelfB
using GAL80TS; ap-GAL4; UAS-GFP (Bar, 10 mm). Discs are stained for E-Cadherin (white) expression and localization. Bottom panel of each image
shows orthogonal optical section of respective genotype. Note delocalization of E-Cad in tumorous tissues caused by the depletion of a component of
PPP and Yki overexpression (higher magnification images are shown for few genotypes). All discs are also stained with DAPI (blue) to visualize nuclei. (B)
Increased expression of MMP1 is observed in tumor discs. Images of wing discs overexpressing Yki alone (crossed to UAS-GFP as control) or in
combination with RNAi-mediated knockdown of Hexim, bin3, NelfA, or NelfB using GAL80TS; ap-GAL4; UAS-GFP (Bar, 100 mm). Wing discs are
stained for MMP1 (white). Note increased MMP1 staining in tumorous tissues caused by the depletion of a component of PPP and Yki overexpression.
All discs are also stained with DAPI (blue) to visualize nuclei.
70 S. Nagarkar et al.
1B). Depletion of the NELF components on their own did not
cause such giant larval phenotype or overgrowth of the wing
disc tissue (Figure S1). These components too did not show
any tumor phenotype in the context of overexpressed EGFR
or NICD (Figure S2).
It was intriguing to find multiple components of the two
spatio-temporally separated protein complexes, involved in
the regulation of transcription elongation, among the tumor
suppressors identified in a genome-wide screen for factors
cooperatingwith Yki in growth regulation (Groth et al. 2019).
Neoplastic transformation induced by Yki combined
with depletion of 7SK snRNP or NELF complexes
Yki is known to promote cell proliferation and cell survival.
Thus, it is possible that larger size of the wing disc tissue
observed upon loss of either 7SK snRNP or NELF complex is a
result of enhancementof growthand survival effect ofYki, and
not a neoplastic transformation. To distinguish between the
two possibilities, we analyzed the tumor tissue using markers
that indicate neoplastic transformation.
First,weexaminedepithelial cell polarity.Neoplastic trans-
formation of an epithelial tissue is accompanied by the loss
of their characteristic apico-basal cell polarity. E-cadherin
(E-Cad) is a subapically localized protein that provides a
convenient marker for epithelial polarization (Tanos and
Rodriguez-Boulan 2008). Wing discs overexpressing Yki
alone showed localization of E-Cad, in a pattern similar to
the wild-type wing discs, although the former discs are much
larger (Figure 2A). This indicated that Yki overexpression
caused overgrowth of the epithelium without perturbation
of epithelial cell polarity. In contrast, when Yki overexpres-
sion was combined with depletion of a component of the 7SK
snRNP complex or the NELF complex, subapical localization
of E-cad was lost or perturbed (Figure 2A). Additionally, we
analyzed F-Actin, which localizes near the apical junctions of
the wing disc epithelial cells, using rhodamine-labeled phal-
loidin. As with E-Cad, we observed loss of apical localization
of F-actin in the Yki expressing tissue depleted of a compo-
nent of the 7SK snRNP or the NELF complex, but not in wing
disc tissue expressing Yki alone (Figure S3). We did not ob-
serve any change in cell polarity, as indicated by E-Cad or
F-Actin localization in wing discs with depletion of compo-
nents of 7SK snRNP and NELF complexes alone (Figure S4A;
data not shown for F-Actin).
The matrix metallo-protease MMP1 has been used as
a marker of epithelial to mesenchymal transition (EMT)
and neoplastic transformation in Drosophila tumor models.
MMP1expression is elevated in tumor models and its deple-
tion by RNAi has been reported to block metastasis (Uhlirova
and Bohmann 2006; Beaucher et al. 2007; Miles et al. 2011).
We examined the effects of depleting components of 7SK
snRNP and NELF complexes in Yki-expressing tissue on
the levels of MMP1 by immunohistochemistry. We ob-
served significantly elevated levels of MMP1 in wing discs
Figure 3 CDK9 cooperates with Yki in tumorigenesis. (A) Larval images
showing growth observed in combination of UAS-CDK9 and UAS-Yki as
compared to UAS-CDK9 alone (crossed to UAS-GFP as control) using
GAL80TS; ap-GAL4; UAS-GFP. The combined overexpression phenocopies
the phenotypes observed in Figure 2B. (B) Characterization of tumor
tissue caused by combined overexpression of CDK9 and Yki using
GAL80TS; ap-GAL4. Top row of images shows wing disc tissue overex-
pressing CDK9 alone, while the bottom row shows combined overexpres-
sion of CDK9 and Yki. Discs in the left column are stained for E-Cadherin
(white) (Bar, 10 mm) and those in the right column are stained for MMP1
(white) expression (Bar, 100 mm). Please note deregulated E-cad localiza-
tion (optical z-sections and two different magnification levels are shown
below the discs) and increased MMP1 expression in tissues that overex-
press both CDK9 and Yki, suggesting their neoplastic tumor state. All
discs are also stained with DAPI (blue) to visualize nuclei. Both the
discs stained for MMP1 are imaged at lower magnification (10X) for
better comparison, as tumorous disc is too large to show at higher
magnification.
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overexpressing Yki and depleted for Bin3, Hexim, or the NELF
complex (Figure 2B, Figure S5A). We observed only marginal
increase (statistically insignificant) inMMP1 levels inwing discs
expressing Yki alone (Figure 2B, Figure S5A). We did not ob-
serve any detectable change in the intensity of MMP1 levels in
the wing discs depleted for the components of 7SK snRNP and
NELF complexes alone (Figure S4B and Figure S5B).
Taken together, tumors formed upon depletion of 7SK
snRNP or NELF complex components in combination with
Yki exhibit neoplastic characters. As neither genetic change
alone produced these results, it appears that they act in
combination to promote neoplasia, a classical mechanism
of cooperative tumorigenesis as known in mammals. These
observations provide evidence that the activity of 7SK snRNP
andNELF complexesmay have a tumor-suppressing function,
but only in the context of elevated Yki activity.
CDK9 is required for Yki-mediated tumorigenesis
The 7SK snRNP and NELF complexes help in maintaining the
paused state of RNA Pol II. Our findings raised the question
of whether pausing of RNA Pol II per se served to limit the
tumor promoting potential of Yki activity. If this is the case,
Figure 4 CDK9 is necessary for Yki-mediated tumorigenesis. (A) Loss of CDK9 rescues tumor phenotype. The images show GFP-expressing wing discs
of various genotypes as indicated. Size of the wing discs may be discerned by the amount of larval space occupied by GFP-expressing tissue. RNAi-
mediated depletion of cdk9 inhibited tumor formation caused by a combination of overexpression of Yki and depletion of a component of the PPP. The
GFP-marked wing tissue is of the same size as in controls. All crosses were using GAL80TS; ap-GAL4; UAS-GFP. (B) Tumorous wing disc phenotypes
caused by the overexpression of Yki in the background of depletion of bin3 or NelfA shown here again as a control to (A). (C) Restoration of apico-basal
polarity in wing disc tissue. The images show wing discs of various genotypes as indicated stained for E-Cad (red). RNAi-mediated depletion of cdk9
restored normal apical localization of E-Cad (optical z-sections are shown below the discs) in wing discs that overexpress Yki and are also depleted for a
component of the PPP. All discs are also stained with DAPI (blue) to visualize nuclei (Bar, 10 mm). (D) Tumorous wing discs (stained for E-Cad) of larvae
overexpressing Yki in the background of depletion of bin3 or NelfA shown here again as a control to (C). (E) Restoration of MMP1 levels. The images
show wing discs of various genotypes as indicated stained MMP1 (white). RNAi-mediated depletion of cdk9 restored normal levels of MMP1 in wing discs
that overexpress Yki and also depleted for a component of the PPP. All discs are also stained with DAPI (blue) to visualize nuclei (Bar, 100 mm). (F) Tumorous
wing discs (stained for MMP1) of larvae overexpressing Yki in the background of depletion of bin3 or NelfA shown here again as a control to (E).
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we reasoned that using an alternative means to release RNA
Pol II should also lead to tumorigenesis in the context of Yki
overexpression. The P-TEFb complex, comprising cycT/CDK9,
is required for release of paused RNA Pol II and effective elon-
gation of mRNA. CDK9 phosphorylates the NELF complex,
leading to eviction of NELF from the pause site. This in turn
facilitates release of paused RNA Pol II, aiding in productive
elongation. CDK9 also acts directly on RNA Pol II, phosphory-
lating it on S5 in the C-terminal domain, a known mark of
elongating RNA Pol II (Jennings 2013). As the P-TEFb com-
plex is normally rendered inactive through sequestration by
7SK snRNP complex, we hypothesized that overexpressing
CDK9 might bypass normal regulation of pausing, leading to
inactivation of NELF complex and RNA Pol II release. Consis-
tent with this hypothesis, we indeed observed massive tissue
overgrowth when Yki was co-expressed with CDK9, while
overexpression of CDK9 alone did not cause any such pheno-
type (Figure 3A). Such overgrowth phenotype was not ob-
served when CDK9 was overexpressed in the background of
elevated activities of EGFR or Notch (Figure S2). This suggests
that PPP-mediated regulation of growth is Yki-specific.
Wing discs expressing UAS-CDK9 together with UAS-Yki
also showed loss of apically localizedE-Cadaswell as elevated
MMP1 expression (Figure 3B), compared to tissue expressing
UAS-CDK9 alone or UAS-Yki alone. This indicates neoplastic
transformation in wing discs co-expressing Yki and CDK9,
similar to the transformation caused by depletion of 7SK
snRNP and NELF complex components in combination with
overexpressed Yki.
As further test of this model, we asked whether CDK9 is
essential for tumorigenic cooperation between depletion of
7SK snRNP complex components and Yki. Depletion of cdk9
effectively suppressed the tissue overgrowth caused by de-
pleting bin3 or Hexim in Yki expressing tissue (Figure 4A).
Those wingdiscs also showed normal apical localization of
E-Cad and wildtype levels of MMP1 expression, suggesting
complete suppression of tumorous growth (Figure 4, B and C).
Given that CDK9 is known to act directly on both NELF
proteins and RNA Pol II, we wondered whether CDK9 activity
would be required in the absence of the NELF complex. As
shown above in the case of removing the 7SK snRNP complex,
depletion of cdk9 suppressed overgrowth caused by RNAi-
mediated depletion of NelfA and overexpression of Yki (Fig-
ure 4A). This was accompanied by restoration of apico-basal
polarity andMMP1 expression towild-type levels (Figure 4, B
and C). This finding provides evidence that alleviation of
pausing by removal of NELF complex is not sufficient without
CDK9 activity. This presumably reflects an importance of ac-
tivation of RNA Pol II by CDK9-mediated phosphorylation.
We then examined if depletion of the complexes associated
with PPP and increased CDK9 levels are sufficient to cause
overgrowth phenotype, or whether the growth is tightly
coupled to the presence of a growth driver such as Yki. De-
pletion of components of 7SK snRNP or NELF complexes in
the background of overexpressed CDK9 did not cause any
growth phenotype or morphological alteration in wing disc
epithelium (Figure 5). This suggests that deregulation of
RNA Pol II pausing is not sufficient on its own to produce
an overgrowth or neoplastic phenotype; yet it does so in the
context of Yki overexpression. In the context of elevated Yki
activity, there appear to be two brakes, each of which must be
removed by CDK9 activity to allow excess Yki to produce
tumors in Drosophila wing disc tissue.
Tumorigenesis induced by alleviation of pausing is
associated with deregulated proteostasis
AsoverexpressionofYkiwasessential, althoughnot sufficient,
to cause neoplastic tumors, genetic experiments above pro-
vided an opportunity to distinguish between Yki-activated
genes that cause simple hyperplastic growth of the discs
(when Yki is overexpressed in a wild-type background) vs.
causing neoplastic growth (when Yki is overexpressed along
with depletion of bin3, Hexim, or NELFs).
We carried out RNA-seq to identify differentially expressed
genes in discs depleted forNelfA andoverexpressingYki aswell
as both individual treatments. We also carried out RNA-seq for
GFP expressing wild-type wing discs as a control. We find that
transcripts corresponding to 776 genes were uniquely upregu-
lated (Figure 6A) and 1009 genes were uniquely downregu-
lated (Figure 6B) in the tumorous wing discs (ap . UAS-Yki;
UAS-NelfARNAi), compared to all other genotypes including
wild-type discs (noncoding transcripts are not included in this
estimation). When compared to the list of direct targets of Yki
(reported by based onChIP-seq data),wefind38 (4.9%) of the
upregulated genes and 84 (8.3%) of the downregulated genes
are presumptive direct targets of Yki (Table S1).
We also observed an enhancement of effect of Yki (com-
pared to wildtype discs) in a subset of transcripts that were
common to nontumorous tissue overexpressing Yki alone
(ap . UAS-Yki) and tumorous ap . UAS-Yki; UAS-NelfARNAi
Figure 5 Yki is the driver of tumorigenesis. Larval images showing phe-
notype of UAS GFP in combination with (left to right) UAS-GFP, UAS-
CDK9 followed by UAS-CDK9 and UAS-bin3RNAi, UAS-CDK9, and
UAS-NelfARNAi. None of them show overgrowth phenotype as ob-
served when Yki is overexpressed, suggesting CDK9 may induce
tumorous growth only in the context of overexpressed Yki. All
crosses were using GAL80TS; ap-GAL4; UAS-GFP.
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tissue. We reasoned that since PPP functions to attenuate
expression of genes, identifying transcripts whose expres-
sion is further up- or downregulated in ap . UAS-Yki; UAS-
NelfARNAi tissue (compared to ap. UAS-Yki) may give a better
indication of the role of PPP in Yki-mediated growth. We find
that transcripts corresponding to 155 genes that are upregu-
lated in both nontumorous ap. UAS-Yki discs and tumorous
ap . UAS-Yki; UAS-NelfARNAi discs, but degree of enhance-
ment was higher in tumorous tissue. Likewise, these tran-
scripts corresponding to 160 genes, whose expression was
downregulated compared to wildtype discs, were common
to both nontumorous and tumorous tissue, but degree of
downregulation was higher in tumorous tissue. Interestingly,
31 (20%) of these upregulated genes (n = 155) and
35 (21.9%) of downregulated genes were presumptive direct
targets of Yki, suggesting that we indeed have capturedmany
targets of Yki that are regulated by PPP andmisregulated due
to RNAi medicated knockdown of many components of the
pausing machinery.
We used genes corresponding to these transcripts to per-
form GO analysis in order to explore gene sets that show
enrichment andmight indicate pathways or processes that are
involved in tumorigenesis. For this purpose, the STRING tool
was utilized (Szklarczyk et al. 2017). STRING output is based
on statistical enrichment score of interactions obtained from
the input compared to a random set of genes from the ge-
nome of the organism, in this case D. melanogaster. STRING
also collates data from manually curated databases of inter-
actions such as Kyoto Encyclopedia of Genes and Genomes
(KEGG) and GO terms.
We observed enrichment for pathways involved in ribo-
some and its biogenesis in the upregulated set (Table 1 and
Figure 6). Interestingly, protein processing in endoplasmic
reticulum, regulators of proteasome function, and different
components of proteasome were enriched among genes
downregulated in tumorous tissues (Table 2). These obser-
vations indicate overall deregulation of protein homeostasis
(proteostasis) in tumors caused by depletion of NelfA in com-
bination with Yki overexpression, consistent with recent data
on human cancers (Ruggero 2013; Pelletier et al. 2017).
Discussion
PPP has emerged as a critical regulatory step in gene expres-
sion (Core and Adelman 2019). It involves stalling of RNA
Pol II 20–60 nucleotides downstream of the transcription
start site, and controlled release of RNA Pol II when trig-
gered by signals from the surroundings. Many studies in re-
cent years have elucidated mechanisms by which RNA Pol II
is stalled and the factors that bring about pausing as well as
release of the paused RNA Pol II. Our in vivo model for tu-
morigenesis has allowed us to elucidate the functions of the
NELF, 7SKsnRNP, and P-TEFb complexes in the context of
growth control in vivo. Previous studies have implicated
NELF in regulating the response of embryonic stem cells
to signaling cues such as fibroblast growth factor (FGF;
Williams et al. 2015). Furthermore, PPP has been shown to
be important for coordination of expression genes involved in
morphogenesis of Drosophila embryo (Lagha et al. 2013).
Our findings provide direct evidence that PPP can limit tumor
Table 1 List of genes whose expression is upregulated in the wing discs of ap-GAL4/UAS-NelfARNAi; UAS-Yki
Aminoacyl-tRNA biosynthesis Ribosome Ribosome biogenesis in eukaryotes
Gene name logFC Gene name logFC Gene name logFC
Slimp 2.124626 RpL24-like 1.256082 Non1 2.292457
Aats-leu 1.413973 RpL5 1.202779 Ns2 0.900983
Aats-thr 0.912237 RpL15 1.130382 RIOK1 1.354352
Aats-cys 0.813931 mRpL28 0.969423 CG12301 0.997310
Aats-tyr-m 1.047768 mRpL9 0.799329 Bka 0.876333
Aats-pro 1.07342 RpS17 0.82042 eIF6 0.745744
Aats-ile 0.73741 mRpL35 0.997681 l(3)72Dn 0.800876
CG4573 1.138148 RpS23 0.782542 CG8064 0.778604
CG1750 1.487797 RpS4 0.775449 Nmd3 0.716537
CG6796 0.925494 RpL27A 0.716573 Mat89Ba 0.713426
CG7441 0.884721 RpL32 0.681588 CG11920 0.750235
CG17259 0.726080 RpL40 0.674508 CG3071 0.713535
Aats-trp 0.732224 RpS29 0.743389 CG33158 0.595732
Aats-asp 0.747097 RpL26 0.620538 CG13185 0.823244
Aats-gly 0.613889 mRpL10 0.692489 CG7246 0.798345
CG5463 1.037030 mRpL3 0.671734 CG8549 0.593618
Aats-ala-m 0.602770 RpL35 0.631348
CG5660 0.663614 RpL27 0.594275
RpL28 0.629209
RpL21 0.600412
RpL22-like 1.081389
RpS3A 0.587288
RpL37A 0.3662
mRpL11 0.624297
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formation in the context of the Hippo tumor suppressor path-
way. Depletion of these factors alone, or even in combination
with overexpression of CDK9, was not sufficient to induce
tumorous growth but did so when combined with overex-
pression of Yki. This cooperation appears to be specific to
Yki-induced tumors as there was no cooperation with other
oncogenic drivers such as EGFR or activated Notch in wing
disc tumor models. This suggests that pausing plays a previously
unappreciated role regulating the output of Hippo pathway in
growth control, thereby limiting its tumorigenic potential.
We were intrigued by the finding that CDK9 activity is
required for Yki-driven tumor formation, even when the
upstreamanddownstreampausingcomplex factorshavebeen
removed. These observations suggest that CDK9 activity is
Table 2 List of genes whose expression is downregulated in the wing discs of ap-GAL4/UAS-NelfARNAI; UAS-Yki
Proteasome Protein processing in endoplasmic reticulum
Gene name logFC Gene name logFC
Rpn7 21.084698 prtp 21.46289
Rpn13 20.949757 Sec61gamma 21.65593
Rpn2 20.900781 Sec61beta 21.31964
Prosalpha3 20.910536 CG5885 21.28449
Rpn3 20.850895 Sec61alpha 21.25184
Rpn1 20.879125 TRAM 21.3381
Pomp 20.795409 Pdi 21.145
Prosalpha5 20.834712 SsRbeta 21.23571
Prosbeta4 20.76685 Sec13 21.01315
Prosbeta7 20.717883 Sec63 20.97489
Prosbeta2 20.706638 CG14476 21.03296
Prosbeta5 20.687177 Sec24CD 20.87522
Prosalpha4 20.694159 Ostgamma 20.97374
Prosbeta6 20.631819 Ost48 20.88256
Rpn10 20.592037 CG4164 21.21065
Rpn12 20.597364 ergic53 20.86625
Plap 20.86843
OstStt3 20.90274
Gp93 20.89197
l(1)G0320 20.88951
CG33303 20.8065
Hsc70-3 20.9493
CG5510 20.81474
p47 20.78553
Crc 20.86323
CG6453 20.81869
Sec23 20.73903
ERp60 20.76882
Der-1 20.80252
Csp 20.64369
CaBP1 20.61193
CG1597 20.67306
Figure 6 Identification of genes potentially in-
volved in Yki-mediated tumorigenesis. (A) Venn
diagram showing number of common and
unique genes, who expression is upregulated
in comparison with ap . GFP from different
genotypes as indicated in the figure. (B) Venn
diagram depicting number of common and
unique genes downregulated in comparison
with ap . GFP from different genotypes.
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required not only to remove the “brake” exerted by NELF
pausing complex, but also required to increase RNA Pol II
activity through direct phosphorylation. Neither alone is suf-
ficient. This suggests an overlapping “belt and suspenders”
regulation to ensure that expression of Yki targets is main-
tained at appropriate levels for normal growth control, while
preventing overexpression, whichmay lead to tumorigenesis.
A mechanism of this sort allows for the possibility that other
growth regulatory or metabolic homeostasis pathways might
impact on the outcome of Yki activity via regulation of the
CDK9. Indeed, evidence of a role for CDK9 in YAP/TAZ-
mediated cell growth via regulation of a subset of YAP/TAZ
target genes in mammalian liver cells has been demonstrated
(Galli et al. 2015). Inhibition of CDK9 activity using flavopir-
idol nullified the effect of YAP S127A mutant form (the con-
stitutively active form of YAP) on the expression of YAP target
genes studied (Galli et al. 2015). Although this observation is
not validated in fly tissues, perhaps PPP (including 7skRNP-,
CDK9-, and NELFs)-dependent regulation of Yki is indepen-
dent of the phosphorylation status of Yki, which implies a
parallel function for PPP rather than it being upstream of Yki.
Our genetic model is also useful to study the importance of
PPP in attenuating transcriptional output at genome wide
scale. Preliminary observations of data generated by RNA-seq
suggest thatmost genes that aredifferentially expressedwhen
Yki is overexpressed show further changes in the same di-
rection (up or down regulation) in combination of Yki over-
expression with depletion of Nelf-A. Furthermore, we also
report deregulation of proteostasis uniquely in tumor tissue.
This is consistent with recent reports that deregulation of
translation and deregulation of protein processing are
important factors in progression of cancers and might be
target for therapy (Ruggero 2013; Pelletier et al. 2017).
To conclude, our study has highlighted additional regula-
tory module on Yki driven tumorigenic activity, which im-
pinges directly on transcription. Itwill be interesting to see the
role of the PPP machinery, which has been reported to be
highly conserved from Drosophila to humans (Peterlin and
Price 2006), in the context of highly conserved Hippo path-
way effectors YAP/TAZ. Considering the reported function of
CDK9 in YAP-driven transcription, and the therapeutic acces-
sibility of CDK9 activity (Galli et al. 2015; Blake et al. 2019), it
is critical to understand the function of 7SK snRNP and NELF
complexes in this context.
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